Status:
UNKNOWN
Decrease Type II Diabetes in Gestational Diabetes Population
Lead Sponsor:
Carmel Medical Center
Conditions:
Gestational Diabetes
Diabetes Mellitus, Type 2
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The goal of the study is to examine the impact of an educational video on the rate of breastfeeding in mothers who had gestational diabetes mellitus, and the rate of type-II diabetes mellitus diagnose...
Eligibility Criteria
Inclusion
- Pregnant individuals aged over 18 years old
- Diagnosed with Gestational Diabetes Mellitus (GDM) by 100gm oral glucose tolerance test (OGTT) done between week 24-28 of gestation, or by other criteria (50gm glucose challenge test (GCT) \>200 mg/dl22 or having one abnormal value in OGTT )
- Having pregestational diabetes (DM-I or DM-II)
- Can read and understand Hebrew
Exclusion
- Delivery of a non-viable fetus
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05202002
Start Date
March 1 2021
End Date
May 30 2023
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carmel MC
Haifa, Israel, 3436212